349 related articles for article (PubMed ID: 28240787)
41. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
[TBL] [Abstract][Full Text] [Related]
42. The incidence and clinical burden of immune thrombocytopenia in pediatric patients in the United States.
Shaw J; Kilpatrick K; Eisen M; Tarantino M
Platelets; 2020; 31(3):307-314. PubMed ID: 31271328
[TBL] [Abstract][Full Text] [Related]
43. Misdiagnosed thrombocytopenia in children and adolescents: analysis of the Pediatric and Adult Registry on Chronic ITP.
Schifferli A; Heiri A; Imbach P; Holzhauer S; Seidel MG; Nugent D; Michel M; Kühne T
Blood Adv; 2021 Mar; 5(6):1617-1626. PubMed ID: 33710335
[TBL] [Abstract][Full Text] [Related]
44. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.
Lozano ML; Revilla N; Gonzalez-Lopez TJ; Novelli S; González-Porras JR; Sánchez-Gonzalez B; Bermejo N; Pérez S; Lucas FJ; Álvarez MT; Arilla MJ; Perera M; do Nascimento J; Campos RM; Casado LF; Vicente V
Ann Hematol; 2016 Jun; 95(7):1089-98. PubMed ID: 27098812
[TBL] [Abstract][Full Text] [Related]
45. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
[TBL] [Abstract][Full Text] [Related]
46. Patterns of inpatient care for newly diagnosed immune thrombocytopenia in US children's hospitals.
Kime C; Klima J; Rose MJ; O'Brien SH
Pediatrics; 2013 May; 131(5):880-5. PubMed ID: 23569091
[TBL] [Abstract][Full Text] [Related]
47. Dengue Fever: A Rare Cause Of Immune Thrombocytopenia.
Ramírez-Fonseca T; Segarra-Torres A; Jaume-Anselmi F; Ramírez-Rivera J
Bol Asoc Med P R; 2015; 107(2):51-3. PubMed ID: 26434084
[TBL] [Abstract][Full Text] [Related]
48. Epidemiology and Clinical Manifestations of Immune Thrombocytopenia.
Kohli R; Chaturvedi S
Hamostaseologie; 2019 Aug; 39(3):238-249. PubMed ID: 30868551
[TBL] [Abstract][Full Text] [Related]
49. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease.
Zeller B; Rajantie J; Hedlund-Treutiger I; Tedgård U; Wesenberg F; Jonsson OG; Henter JI;
Acta Paediatr; 2005 Feb; 94(2):178-84. PubMed ID: 15981751
[TBL] [Abstract][Full Text] [Related]
50. Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia.
Ekstrand C; Linder M; Cherif H; Kieler H; Bahmanyar S
Blood Coagul Fibrinolysis; 2019 Oct; 30(7):350-356. PubMed ID: 31433305
[TBL] [Abstract][Full Text] [Related]
51. Influence of the American Society of Hematology guidelines on the management of newly diagnosed childhood immune thrombocytopenia.
Schultz CL; Mitra N; Schapira MM; Lambert MP
JAMA Pediatr; 2014 Oct; 168(10):e142214. PubMed ID: 25288142
[TBL] [Abstract][Full Text] [Related]
52. Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.
Michel M; Rauzy OB; Thoraval FR; Languille L; Khellaf M; Bierling P; Godeau B
Am J Hematol; 2011 Dec; 86(12):980-4. PubMed ID: 21956157
[TBL] [Abstract][Full Text] [Related]
53. Controversies in the treatment of immune thrombocytopenia.
Cuker A; Cines DB; Neunert CE
Curr Opin Hematol; 2016 Sep; 23(5):479-85. PubMed ID: 27380558
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
Schoonen WM; Kucera G; Coalson J; Li L; Rutstein M; Mowat F; Fryzek J; Kaye JA
Br J Haematol; 2009 Apr; 145(2):235-44. PubMed ID: 19245432
[TBL] [Abstract][Full Text] [Related]
55. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course.
Ayesh MH; Alawneh K; Khassawneh B; Khader Y; Kasasbeh A
Clin Appl Thromb Hemost; 2013 Jun; 19(3):327-30. PubMed ID: 22275396
[TBL] [Abstract][Full Text] [Related]
56. Relation of interleukin-10 Promoter Polymorphisms to Adult Chronic Immune Thrombocytopenic Purpura in a Cohort of Egyptian Population.
El Ghannam D; Fawzy IM; Azmy E; Hakim H; Eid I
Immunol Invest; 2015; 44(7):616-26. PubMed ID: 26436850
[TBL] [Abstract][Full Text] [Related]
57. Primary versus secondary immune thrombocytopenia in adults; a comparative analysis of clinical and laboratory attributes in newly diagnosed patients in Southern Pakistan.
Sultan S; Ahmed SI; Murad S; Irfan SM
Med J Malaysia; 2016 Oct; 71(5):269-274. PubMed ID: 28064294
[TBL] [Abstract][Full Text] [Related]
58. [Clinical analysis of pregnancy complicated with severe thrombocytopenia].
Wang DP; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):401-5. PubMed ID: 21029587
[TBL] [Abstract][Full Text] [Related]
59. Incidence of adult primary immune thrombocytopenia in England-An update.
Doobaree IU; Conway K; Miah H; Miah A; Makris M; Hill Q; Cooper N; Bradbury C; Newland A; Provan D; McDonald V;
Eur J Haematol; 2022 Sep; 109(3):238-249. PubMed ID: 35670140
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of anti-D for treatment of adults with immune thrombocytopenia.
Naithani R; Kumar R; Mahapatra M; Tyagi S; Saxena R
Platelets; 2009 Nov; 20(7):525-7. PubMed ID: 19852693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
